The first generic two-rod sub-dermal levonorgestrel 75mg implant product has received a positive result from the Expert Review Panel (ERP), making it the first of its kind to reach the quality standard for international procurement.
The WHO PQ Programme have announced the prequalification of an new levonorgestrel emergency contraceptive.
The presentations from the different working groups and general meeting are now available on the RHSC website.
Concept Foundation will be present at the Reproductive Health Supplies Coalition (RHSC) 16th Membership Meeting in Oslo, Norway next week, from 5-9 October.
The topmost drug technical advisory body of the Union Health Ministry in India has recommended the introduction of the injectable contraceptive DMPA
Concept Foundation is pleased to announce that India’s Drugs Technical Advisory Board recently agreed to the introduction of Depot-medroxyprogesterone acetate, or DMPA, under the National Family Planning Programme.
Concept Foundation is pleased to announce the WHO prequalification of the first generic combined oral contraceptive pill (desogestrel and ethinylestradiol formulation), manufactured by Famycare India.
Concept Foundation is pleased to announce the WHO prequalification of the first generic emergency contraceptive product, Levonorgestrel 0.75mg, manufactured by Famycare in India.